Lucid Diagnostics/$LUCD
About Lucid Diagnostics
Ticker
Industry
Employees
LUCD Metrics
$45M
-
-$1.13
1.42
-
Price and volume
Market cap
$45M
Beta
1.42
52-week high
$1.58
52-week low
$0.63
Average daily volume
470K
Financial strength
Current ratio
1.181
Quick ratio
1.104
Long term debt to equity
31.729
Total debt to equity
206.153
Interest coverage (TTM)
-1,504.33%
Management effectiveness
Return on assets (TTM)
-101.02%
Return on equity (TTM)
-1,007.83%
Valuation
Price to revenue (TTM)
9.068
Price to book
-0.85
Price to tangible book (TTM)
-0.84
Price to free cash flow (TTM)
-0.848
Growth
Revenue change (TTM)
179.27%
Earnings per share change (TTM)
-19.69%
3-year revenue growth (CAGR)
175.65%
3-year earnings per share growth (CAGR)
-6.62%
What the Analysts think about LUCD
Analyst Ratings
LUCD Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
LUCD Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
LUCD News
FAQs
What’s the current market cap for Lucid Diagnostics stock?
What is the P/E ratio for Lucid Diagnostics stock?
Does Lucid Diagnostics stock pay dividends?
No, Lucid Diagnostics (LUCD) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Lucid Diagnostics dividend payment date?
Lucid Diagnostics (LUCD) stock does not pay dividends to its shareholders.
What is the beta indicator for Lucid Diagnostics?
Lucid Diagnostics (LUCD) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.